Xigen
is developing innovative therapeutic peptides for a broad range of
diseases with underserved medical needs and proven commercial value,
with a focus on inflammation. Xigen’s technology
platform enables the design and synthesis of cell-penetrating peptides
with enhanced metabolic stability, using proprietary carrier motifs to
selectively deliver them to intracellular targets.
|
![]() |
||||||||
PRODUCTS overview
Xigen's strategy is to identify
important control elements (hubs) for major debilitating diseases... ![]()
Partnerships
Xigen is involved in
partnering activities...
TECHNOLOGY overview
Xigen relies for its drugs on its intracellular
Peptide Transporter technology (ICPTTM)... |
![]() |
![]() |
|||||||
![]() |
|||||||||
![]() |
![]() |
Web creation : Alchimie ![]() |
![]() |